세계의 핵산 치료제 CDMO 시장 : 제품 유형별, 서비스별, 용도별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 예측(2023-2030년)

Nucleic Acid Therapeutics CDMO Market, By Product Type, By Service, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

US $ 3,250 ￦ 4,612,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,598,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 8,017,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

보고서 하이라이트

핵산치료제 CDMO 시장 규모는 2022년 117억 5,630만 달러로 평가되었고 2023년부터 2030년까지 복합 연간 성장률(CAGR) 10.3%로 확대될 전망입니다

핵산 치료제 CDMO 시장 - 시장 역학

핵산 치료제의 진보, 복잡한 제조 절차, 투자 증가가 시장 수요를 촉진

이 시장은 주로 핵산 치료제의 진보, 복잡한 제조 절차 및 투자 증가에 의해 지원됩니다. 또한, 핵산 치료제에 대한 규제 승인 증가와 맞춤형 의료에 대한 세계 수요 증가는 비용 효과적인 CDMO 서비스의 필요성을 촉진하고 결과적으로 시장 확대를 뒷받침할 계획입니다. 핵산 치료는 개인의 유전자 구성에 맞는 개인화된 건강 관리를 제공합니다. 정밀의료 및 표적 치료에 대한 수요가 증가함에 따라 핵산 기반 의약품의 잠재력을 활용하려는 제약 기업과 바이오 최종사용자 기업에게 이러한 CDMO는 중요한 파트너로 부상하고 있습니다. 엄격한 품질 기준을 준수하고 규제 복잡성을 극복하고 최첨단 기술을 채택한 CDMO의 노력은 이러한 복잡한 분자의 효율적이고 확장 가능한 생산을 촉진합니다. 그 결과 혁신적인 핵산 기반 치료법에 대한 진보와 접근이 촉진되어 다양한 의료 요구를 충족시킬 수 있습니다.

핵산 치료제 CDMO 시장 - 주요 인사이트

리서치 애널리스트의 분석에 따르면 세계 시장은 예측 기간 동안 약 복합 연간 성장률(CAGR) 10.3%로 매년 성장할 것으로 추정됩니다.

제품 유형별로 RNA 기반 치료제가 2022년에 가장 높은 시장 점유율을 보였습니다.

서비스별로 제조 서비스는 2022년 주요 유형이었습니다.

용도별로는 2022년에는 종양학이 주요 유형이었습니다.

지역별로 북미는 2022년 주요 수익원이었습니다.

핵산 치료제 CDMO 시장-세그먼테이션 분석 :

세계 핵산 치료제 CDMO 시장은 제품 유형, 서비스, 용도, 최종 사용자, 지역에 따라 구분됩니다.

시장은 제품 유형에 따라 두 가지 범주로 나뉩니다. 유전자 치료와 RNA 기반 치료입니다. 2022년에는 RNA 기반 치료 분야가 세계 시장의 지배적 세력으로 부상했습니다. ClinicalTrials.gov의 데이터는 다양한 질병에 대한 RNA 요법을 포함한 3,500 가지 이상의 임상시험이 진행 중임을 보여줍니다. 최근의 임상시험에서 얻은 유망한 결과는 다양한 질병에 대한 RNA 기반 약물의 큰 가능성을 뒷받침하고 있으며,이 분야의 성장을 가속할 것으로 예상됩니다.

시장은 서비스별로 4가지 범주로 분류된다: 프로세스 개발 및 최적화, 제조 서비스, 분석 및 품질 관리 서비스 등. 2022년에는 제조 서비스 카테고리가 큰 판매 점유율을 차지했습니다. RNA 요법과 유전자 요법을 포함한 핵산 기반 요법은 제조에 대한 전문 지식과 전문성이 필요합니다. 핵산 제조에 특화된 CDMO는 이러한 치료법에 대한 깊은 이해를 길러 경쟁력을 높이고 있습니다. 핵산 치료제 CDMO 시장에서 서비스는 프로세스 개척, 최적화, 제조 서비스, 분석 및 품질 관리 서비스 등으로 구분됩니다.

핵산 치료제 CDMO 시장 - 지리적 인사이트

지역적으로, 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카의 각 지역으로 퍼져 있습니다. 이 지역은 비즈니스를 전개하는 국가에 따라 더 나뉩니다.

핵산 치료제 CDMO 시장 - 경쟁 구도:

핵산개발제조위탁기관(CDMO)의 역동적인 영역에서 기업은 다면적인 접근법을 채택하여 전략적으로 업계를 탐색하고 있습니다. 이들 기업들은 mRNA, siRNA, 유전자 편집, 올리고뉴클레오티드 합성 등의 각 분야에 주력함으로써 전문성을 높이고 있습니다. 이러한 전문 분야에서 전문 지식을 연마함으로써 CDMO는 고객의 특정 요구 사항에 맞는 맞춤형 솔루션과 최적화된 서비스를 제공합니다. 동시에 최첨단 최종 사용자와 인프라에 대한 대규모 투자에 중점을 두어 핵산 제조 공정의 최신 진보를 갖춘 시설을 확보하고 있습니다. 컴플라이언스는 FDA 및 EMA와 같은 기관이 설정한 규제 기준을 충족하고 이를 초과하는 데 엄격한 주의를 기울이면서 그들의 업무의 기본적인 측면으로 남아 있습니다. 또한 이 회사의 서비스는 유연성과 확장성을 중시하고 있으며, 다양한 프로젝트의 규모와 사양에 대응하는 적응성이 높은 제조 솔루션이 가능해지고 있습니다. 이 적응성은 제약 및 바이오 최종사용자 파트너의 진화하는 요구에 대응하는 민첩성을 촉진하여 경쟁 시장에서의 입지를 견고하게 만듭니다.

목차

제1장 핵산 치료제 CDMO 시장 개요

• 조사 범위
• 시장 추정 연도

제2장 주요 요약

• 시장 분석
• 경쟁 인사이트

제3장 핵산 치료제 CDMO의 주요 시장 동향

• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 향후 시장 동향

제4장 핵산 치료제 CDMO 업계 조사

• PEST 분석
• Porter's Five Forces 분석
• 성장 전망 맵핑
• 규제 틀의 분석

제5장 핵산 치료제 CDMO 시장 : COVID-19 감염증의 영향 분석

• 신형 코로나바이러스 감염증 이전의 영향 분석
• 신형 코로나바이러스 감염증 후의 영향 분석

제6장 핵산 치료제 CDMO 시장 상황

• 핵산치료제 CDMO 시장 점유율 분석(2022년)
• 주요 제조업체별 분석 데이터
  • 기존 기업의 분석
  • 신흥기업의 분석

제7장 핵산 치료제 CDMO 시장 : 제품 유형별

• 개요
  • 제품 유형별 부문 점유율 분석
  • 유전자 치료
  • RNA 기반 치료

제8장 핵산 치료제 CDMO 시장 : 서비스별

• 개요
  • 서비스별 부문 점유율 분석
  • 프로세스 개발 및 최적화
  • 제조 서비스
  • 분석 및 품질 관리 서비스
  • 기타

제9장 핵산 치료제 CDMO 시장 : 용도별

• 개요
  • 용도별 부문 점유율 분석
  • 종양
  • 유전성 질환
  • 감염증
  • 기타

제10장 핵산 치료제 CDMO 시장 : 최종 사용자별

• 개요
  • 최종 사용자별 부문 점유율 분석
  • 제약회사
  • 정부 및 학술연구기관
  • 바이오테크놀러지 기업

제11장 핵산 치료제 CDMO 시장 :지역별

• 소개
• 북미
  • 개요
  • 북미의 주요 제조업체
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽의 주요 제조업체
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 러시아
  • 네덜란드
  • 스웨덴
  • 폴란드
  • 기타
• 아시아태평양(APAC)
  • 개요
  • 아시아태평양의 주요 제조업체
  • 인도
  • 중국
  • 일본
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 필리핀
  • 기타
• 라틴아메리카
  • 개요
  • 라틴아메리카의 주요 제조업체
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카
  • 개요
  • 중동 및 아프리카의 주요 제조업체
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 이스라엘
  • 터키
  • 알제리
  • 이집트
  • 기타

제12장 주요 벤더 분석- 핵산 치료제 CDMO 업계

• 경쟁 대시보드
• 기업 프로파일
  • Catalent
  • Thermo Fisher Scientific
  • Lonza
  • FUJIFILM Diosynth Biotechnologies
  • Cognate BioServices
  • Eurofins Genomics
  • Sirion Biotech
  • Oxford Biomedica
  • Danaher(Aldevron)
  • Others

제13장 애널리스트의 전방위 전망

BJH

영문 목차

영문목차

REPORT HIGHLIGHT

Nucleic Acid Therapeutics CDMO Market size was valued at USD 11,756.3 Million in 2022, expanding at a CAGR of 10.3% from 2023 to 2030.

Nucleic acid Contract Development and Manufacturing Organizations (CDMOs) hold a critical position in the ever-changing realm of pharmaceutical advancements. Their specialized proficiency in developing, manufacturing, and producing nucleic acid-based therapeutics, such as mRNA, siRNA, gene therapies, and oligonucleotides, underscores their importance in turning innovative research into practical treatments.

Nucleic Acid Therapeutics CDMO Market- Market Dynamics

Advancements in nucleic acid therapeutics, intricate manufacturing procedures, and heightened investments to propel market demand

The market is primarily steered by advancements in nucleic acid therapeutics, intricate manufacturing procedures, and heightened investments. Additionally, the increasing regulatory approvals for nucleic acid therapeutics and the global rise in demand for personalized medicine are poised to drive the need for cost-effective CDMO services, consequently propelling market expansion. Nucleic acid treatments offer personalized healthcare by tailoring to an individual's genetic makeup. With the escalating demand for precision medicine and targeted therapies, these CDMOs emerge as vital partners for pharmaceutical and bioEnd User firms aiming to leverage the potential of nucleic acid-based medications.Their commitment to upholding rigorous quality standards, navigating through regulatory complexities, and employing state-of-the-art technologies facilitates efficient and scalable production of these intricate molecules. Consequently, this drives advancements and accessibility to transformative nucleic acid-based therapies, addressing a wide array of medical necessities.

Nucleic Acid Therapeutics CDMO Market- Key Insights

• As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.3% over the forecast period (2023-2030)

• Based on product type segmentation, RNA-based therapies was predicted to show maximum market share in the year 2022

• Based on Service segmentation, manufacturing services was the leading type in 2022

• Based on Application segmentation, Oncology was the leading type in 2022

• On the basis of region, North America was the leading revenue generator in 2022

Nucleic Acid Therapeutics CDMO Market- Segmentation Analysis:

• The Global Nucleic Acid Therapeutics CDMO Market is segmented on the basis of Product Type, Service, Application, End User, and Region.

• The market is divided into two categories based on product type: Gene Therapy and RNA-based Therapies. In 2022, the RNA-based therapies sector emerged as the dominant force in the global market. ClinicalTrials.gov data revealed over 3,500 ongoing clinical trials involving RNA therapies for diverse diseases. Encouraging results from recent trials underscore the substantial potential of RNA-based medications in addressing various illnesses, anticipated to propel the growth of this segment.

• The market is divided into four categories based on Service: Process Development and Optimization, Manufacturing Services, Analytical and Quality Control Services and Others. The manufacturing services category commanded a significant revenue share in 2022. Nucleic acid-based therapies, encompassing RNA and gene therapies, demand specialized knowledge and expertise in manufacturing. CDMOs exclusively focused on nucleic acid manufacturing have cultivated an in-depth understanding of these therapies, granting them a competitive edge. Within the nucleic acid therapeutics CDMO market, services are further segmented into process development and optimization, manufacturing services, analytical and quality control services, and others.

Nucleic Acid Therapeutics CDMO Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Nucleic Acid Therapeutics CDMO Market- Competitive Landscape:

Within the dynamic sphere of nucleic acid Contract Development and Manufacturing Organizations (CDMOs), companies navigate the industry strategically by adopting multifaceted approaches. These entities prioritize specialization by focusing efforts on mRNA, siRNA, gene editing, or oligonucleotide synthesis segments. By refining expertise in these specialized domains, CDMOs offer customized solutions and optimized services tailored to their clients' specific requirements. Concurrently, they emphasize substantial investments in state-of-the-art End User and infrastructure, ensuring their facilities are equipped with the latest advancements in nucleic acid manufacturing processes. Compliance remains a fundamental aspect of their operations, with stringent attention on meeting and exceeding regulatory standards set by bodies like the FDA or EMA. Moreover, flexibility and scalability are emphasized in their services, enabling adaptable manufacturing solutions accommodating diverse project sizes and specifications. This adaptability facilitates agility in response to the evolving needs of pharmaceutical and bioEnd User partners, consolidating their position in the competitive market.

Recent Developments:

In April 2023, Exothera collaborated with Quantoom Biosciences to leverage Quantoom's innovative Nfinity End User-a cutting-edge continuous production platform crafted for RNA. This partnership positions Exothera as the pioneering Contract Development and Manufacturing Organization (CDMO) globally to offer an off-the-shelf service for continuous RNA production, expanding its expertise in the RNA manufacturing domain.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET KEY PLAYERS

• Catalent
• Thermo Fisher Scientific
• Lonza
• FUJIFILM Diosynth Biotechnologies
• Cognate BioServices
• Eurofins Genomics
• Sirion Biotech
• Oxford Biomedica
• Danaher (Aldevron)
• Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY PRODUCT TYPE

• Gene Therapy
• RNA-based Therapies

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY SERVICE

• Process Development and Optimization
• Manufacturing Services
• Analytical and Quality Control Services
• Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY APPLICATION

• Oncology
• Genetic Disorders
• Infectious Diseases
• Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY END USER

• Pharmaceutical Companies
• Government & Academic Research Institutes
• Biotech Companies

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY REGION

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Nucleic Acid Therapeutics CDMO Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Nucleic Acid Therapeutics CDMO Market Snippet by Product Type
  • 2.1.2. Nucleic Acid Therapeutics CDMO Market Snippet by Service
  • 2.1.3. Nucleic Acid Therapeutics CDMO Market Snippet by Application
  • 2.1.4. Nucleic Acid Therapeutics CDMO Market Snippet by End User
  • 2.1.5. Nucleic Acid Therapeutics CDMO Market Snippet by Country
  • 2.1.6. Nucleic Acid Therapeutics CDMO Market Snippet by Region
• 2.2. Competitive Insights

3. Nucleic Acid Therapeutics CDMO Key Market Trends

• 3.1. Nucleic Acid Therapeutics CDMO Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Nucleic Acid Therapeutics CDMO Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Nucleic Acid Therapeutics CDMO Market Opportunities
• 3.4. Nucleic Acid Therapeutics CDMO Market Future Trends

4. Nucleic Acid Therapeutics CDMO Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Nucleic Acid Therapeutics CDMO Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Nucleic Acid Therapeutics CDMO Market Landscape

• 6.1. Nucleic Acid Therapeutics CDMO Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Nucleic Acid Therapeutics CDMO Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
  • 7.1.2. Gene Therapy
  • 7.1.3. RNA-based Therapies

8. Nucleic Acid Therapeutics CDMO Market - By Service

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Service, 2022 & 2030 (%)
  • 8.1.2. Process Development and Optimization
  • 8.1.3. Manufacturing Services
  • 8.1.4. Analytical and Quality Control Services
  • 8.1.5. Others

9. Nucleic Acid Therapeutics CDMO Market - By Application

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
  • 9.1.2. Oncology
  • 9.1.3. Genetic Disorders
  • 9.1.4. Infectious Diseases
  • 9.1.5. Others

10. Nucleic Acid Therapeutics CDMO Market - By End User

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
  • 10.1.2. Pharmaceutical Companies
  • 10.1.3. Government & Academic Research Institutes
  • 10.1.4. Biotech Companies

11. Nucleic Acid Therapeutics CDMO Market- By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.3.9. Italy
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.9.4. Italy Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.3.9.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.9.6. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.3.10. United Kingdom
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.10.4. United Kingdom Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.3.11. France
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.11.4. France Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.3.11.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.11.6. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.3.12. Russia
    • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.12.3. Russia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.3.12.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.12.5. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.3.13. Netherlands
    • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.13.3. Netherlands Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.3.15. Poland
    • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.15.3. Poland Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.3.15.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.15.5. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.3.16. Rest of Europe
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Asia Pacific
  • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 11.4.5. Asia Pacific Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
  • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.4.8. India
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.8.4. India Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.4.8.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.8.6. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.4.9. China
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.9.4. China Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.4.9.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.9.6. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.4.13. Thailand
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.13.4. Thailand Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.4.14. Indonesia
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.14.4. Indonesia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.4.16. Rest of APAC
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.16.4. Rest of APAC Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
• 11.5. Latin America
  • 11.5.1. Overview
  • 11.5.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Latin America
  • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 11.5.5. Latin America Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
  • 11.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.5.7. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
• 11.6. Middle East and Africa
  • 11.6.1. Overview
  • 11.6.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Middle East and Africa
  • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 11.6.5. Middle East and Africa Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
  • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.6.14. Rest of MEA
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.14.4. Rest of MEA Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Nucleic Acid Therapeutics CDMO Industry

• 12.1. Competitive Dashboard
• 12.2. Company Profiles
  • 12.2.1. Catalent
  • 12.2.2. Thermo Fisher Scientific
  • 12.2.3. Lonza
  • 12.2.4. FUJIFILM Diosynth Biotechnologies
  • 12.2.5. Cognate BioServices
  • 12.2.6. Eurofins Genomics
  • 12.2.7. Sirion Biotech
  • 12.2.8. Oxford Biomedica
  • 12.2.9. Danaher (Aldevron)
  • 12.2.10. Others

13. 360 Degree Analyst View

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us

관련자료